Christopher T. Bever

7.7k total citations · 1 hit paper
116 papers, 5.3k citations indexed

About

Christopher T. Bever is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Neurology. According to data from OpenAlex, Christopher T. Bever has authored 116 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pathology and Forensic Medicine, 25 papers in Molecular Biology and 24 papers in Neurology. Recurrent topics in Christopher T. Bever's work include Multiple Sclerosis Research Studies (41 papers), Stroke Rehabilitation and Recovery (18 papers) and Peripheral Neuropathies and Disorders (11 papers). Christopher T. Bever is often cited by papers focused on Multiple Sclerosis Research Studies (41 papers), Stroke Rehabilitation and Recovery (18 papers) and Peripheral Neuropathies and Disorders (11 papers). Christopher T. Bever collaborates with scholars based in United States, France and Canada. Christopher T. Bever's co-authors include Hermano Igo Krebs, Susan I. V. Judge, Bruce T. Volpe, George F. Wittenberg, Neville Hogan, Susan S. Conroy, Jodie K. Haselkorn, Tapas K. Makar, David Trisler and Lorie Richards and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and SHILAP Revista de lepidopterología.

In The Last Decade

Christopher T. Bever

115 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Robot-Assisted Therapy for Long-Term Upper-Limb Impairment after Stroke

2010 993 citations Albert Lo, Peter Guarino et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher T. Bever United States	37	1.8k	1.4k	1.1k	852	785	116	5.3k
Patrizio Sale Italy	38	1.3k 0.7×	725 0.5×	256 0.2×	556 0.7×	671 0.9×	104	4.2k
Lorna Paul United Kingdom	48	737 0.4×	539 0.4×	1.5k 1.4×	322 0.4×	1.7k 2.2×	229	7.2k
Maria Grazia Grasso Italy	35	995 0.6×	829 0.6×	1.2k 1.1×	126 0.1×	738 0.9×	126	3.8k
Fletcher McDowell United States	38	694 0.4×	2.3k 1.6×	1.0k 1.0×	245 0.3×	1.1k 1.4×	142	5.9k
Robert M. Levy United States	51	378 0.2×	1.9k 1.3×	1.3k 1.2×	221 0.3×	1.3k 1.6×	194	11.0k
Frank Mastaglia Australia	55	478 0.3×	2.5k 1.7×	980 0.9×	1.0k 1.2×	761 1.0×	336	10.0k
Raffaele Nardone Austria	41	344 0.2×	1.4k 1.0×	648 0.6×	438 0.5×	1.7k 2.2×	264	6.0k
H. Bart van der Worp Netherlands	33	795 0.5×	2.0k 1.4×	119 0.1×	261 0.3×	454 0.6×	77	5.7k
Harald Nyland Norway	45	399 0.2×	1.6k 1.1×	3.4k 3.2×	139 0.2×	804 1.0×	172	6.5k
Frank Weber Germany	43	141 0.1×	934 0.7×	1.1k 1.0×	317 0.4×	346 0.4×	167	5.5k

Countries citing papers authored by Christopher T. Bever

Since Specialization

Citations

This map shows the geographic impact of Christopher T. Bever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher T. Bever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher T. Bever more than expected).

Fields of papers citing papers by Christopher T. Bever

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher T. Bever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher T. Bever. The network helps show where Christopher T. Bever may publish in the future.

Co-authorship network of co-authors of Christopher T. Bever

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher T. Bever. A scholar is included among the top collaborators of Christopher T. Bever based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher T. Bever. Christopher T. Bever is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Makar, Tapas K., Poornachander R. Guda, Kaspar Keledjian, et al.. (2023). Immunomodulatory therapy with glatiramer acetate reduces endoplasmic reticulum stress and mitochondrial dysfunction in experimental autoimmune encephalomyelitis. Scientific Reports. 13(1). 5635–5635. 6 indexed citations

Nimmagadda, Vamshi K.C., et al.. (2016). SIRT1 and NAD + precursors: Therapeutic targets in multiple sclerosis a review. Journal of Neuroimmunology. 304. 29–34. 33 indexed citations

Makar, Tapas K., Vamshi K.C. Nimmagadda, Ishwar Singh, et al.. (2016). TrkB agonist, 7,8-dihydroxyflavone, reduces the clinical and pathological severity of a murine model of multiple sclerosis. Journal of Neuroimmunology. 292. 9–20. 24 indexed citations

Makar, Tapas K., Volodymyr Gerzanich, Vamshi K.C. Nimmagadda, et al.. (2015). Silencing of Abcc8 or inhibition of newly upregulated Sur1-Trpm4 reduce inflammation and disease progression in experimental autoimmune encephalomyelitis. Journal of Neuroinflammation. 12(1). 210–210. 57 indexed citations

Makar, Tapas K., Vamshi K.C. Nimmagadda, David Trisler, & Christopher T. Bever. (2014). Cell-Based Delivery of Brain-Derived Neurotrophic Factor in Experimental Allergic Encephalomyelitis. Journal of Interferon & Cytokine Research. 34(8). 641–647. 8 indexed citations

Lo, Albert, Peter Guarino, Lorie Richards, et al.. (2010). Robot-Assisted Therapy for Long-Term Upper-Limb Impairment after Stroke. New England Journal of Medicine. 362(19). 1772–1783. 993 indexed citations breakdown →

Bever, Christopher T.. (2009). 10 Questions About 4-Aminopyridine and the Treatment of Multiple Sclerosis. The Neurologist. 15(3). 161–162. 2 indexed citations

Halperin, John, Eugene D. Shapiro, Eric L. Logigian, et al.. (2007). Practice Parameter: Treatment of nervous system Lyme disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology [RETIRED]. Neurology. 69(1). 91–102. 178 indexed citations

Judge, Susan I. V., Jennifer M. Lee, Christopher T. Bever, & Paul M. Hoffman. (2006). Voltage-gated potassium channels in multiple sclerosis: Overview and new implications for treatment of central nervous system inflammation and degeneration. The Journal of Rehabilitation Research and Development. 43(1). 111–111. 51 indexed citations

10.

MacClellan, Leah R., Douglas D. Bradham, Jill Whitall, et al.. (2005). Robotic upper-limb neurorehabilitation in chronic stroke patients. The Journal of Rehabilitation Research and Development. 42(6). 717–717. 64 indexed citations

11.

Judge, Susan I. V., et al.. (2002). Determinants of 4-Aminopyridine Sensitivity in a Human Brain Kv1.4 K+ Channel: Phenylalanine Substitutions in Leucine Heptad Repeat Region Stabilize Channel Closed State. Molecular Pharmacology. 61(4). 913–920. 1 indexed citations

12.

Li, Qingdi Q. & Christopher T. Bever. (2001). Glatiramer acetate blocks interleukin-1-dependent nuclear factor-κB activation and RANTES expression in human U-251 MG astroglial cells. Molecular Brain Research. 87(1). 48–60. 15 indexed citations

13.

Ćeller, A., et al.. (2000). Performance of the dynamic single photon emission computed tomography (dSPECT) method for decreasing or increasing activity changes. Physics in Medicine and Biology. 45(12). 3525–3543. 36 indexed citations

14.

Friend, Karen B., Bernard M. Rabin, Lowell D. Groninger, et al.. (1999). Language Functions in Patients with Multiple Sclerosis. The Clinical Neuropsychologist. 13(1). 78–94. 56 indexed citations

15.

Bever, Christopher T., Hillel Panitch, & Kenneth P. Johnson. (1994). Increased cathepsin B activity in peripheral blood mononuclear cells of multiple sclerosis patients. Neurology. 44(4). 745–745. 29 indexed citations

16.

Bever, Christopher T., Dale E. McFarlin, & Hilton B. Levy. (1992). A Comparison of Interferon Responses to Poly ICLC in Males and Females. Journal of Interferon Research. 1992(special_issue). 85–90. 9 indexed citations

17.

Bever, Christopher T. & Richard Asofsky. (1991). Augmented IgG anti-acetylcholine receptor response following chronic penicillamine administration. Journal of Neuroimmunology. 35(1-3). 131–137. 2 indexed citations

18.

Bever, Christopher T., et al.. (1990). Preliminary trial of 3,4‐diaminopyridine in patients with multiple sclerosis. Annals of Neurology. 27(4). 421–427. 56 indexed citations

19.

Bever, Christopher T., Henry F. McFarland, Dale E. McFarlin, & Hilton B. Levy. (1988). The Kinetics of Interferon Induction by Poly ICLC in Humans. Journal of Interferon Research. 8(4). 419–425. 8 indexed citations

20.

Bever, Christopher T., Dale E. McFarlin, & Hilton B. Levy. (1985). A Comparison of Interferon Responses to Poly ICLC in Males and Females. Journal of Interferon Research. 5(3). 423–428. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact